These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 12574947

  • 1. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM.
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [Abstract] [Full Text] [Related]

  • 2. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM, Martínez-Bisbal MC, Boscá I, Valero C, Coret F, Martínez-Granados B, Marti-Bonmati L, Mir A, Celda B, Casanova B.
    Neurology; 2007 Jul 03; 69(1):63-7. PubMed ID: 17606882
    [Abstract] [Full Text] [Related]

  • 3. Localized (1)H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis.
    Sarchielli P, Presciutti O, Tarducci R, Gobbi G, Alberti A, Pelliccioli GP, Chiarini P, Gallai V.
    J Neurol; 2002 Jul 03; 249(7):902-10. PubMed ID: 12140676
    [Abstract] [Full Text] [Related]

  • 4. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.
    Neuroimage; 2006 Jan 15; 29(2):637-42. PubMed ID: 16126413
    [Abstract] [Full Text] [Related]

  • 5. [Total brain T2-hyperintense lesion-volume and the axonal damage in the normal-appearing white matter of brainstem in early lapsing-remitting multiple sclerosis].
    Pascual-Lozano AM, Martínez-Bisbal MC, Boscá-Blasco I, Valero-Merino C, Coret-Ferrer F, Martí-Bonmatí L, Martínez-Granados B, Celda B, Casanova-Estruch B.
    Rev Neurol; 2006 Jan 15; 45(8):468-73. PubMed ID: 17948212
    [Abstract] [Full Text] [Related]

  • 6. The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
    Tartaglia MC, Narayanan S, Francis SJ, Santos AC, De Stefano N, Lapierre Y, Arnold DL.
    Arch Neurol; 2004 Feb 15; 61(2):201-7. PubMed ID: 14967766
    [Abstract] [Full Text] [Related]

  • 7. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
    Gadea M, Martínez-Bisbal MC, Marti-Bonmatí L, Espert R, Casanova B, Coret F, Celda B.
    Brain; 2004 Jan 15; 127(Pt 1):89-98. PubMed ID: 14506072
    [Abstract] [Full Text] [Related]

  • 8. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
    Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP.
    Ann Neurol; 1994 Jul 15; 36(1):76-82. PubMed ID: 8024266
    [Abstract] [Full Text] [Related]

  • 9. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
    Fu L, Wolfson C, Worsley KJ, De Stefano N, Collins DL, Narayanan S, Arnold DL.
    NMR Biomed; 1996 Dec 15; 9(8):339-46. PubMed ID: 9176888
    [Abstract] [Full Text] [Related]

  • 10. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2009 Jul 15; 15(7):789-94. PubMed ID: 19465450
    [Abstract] [Full Text] [Related]

  • 11. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J, Pelletier D, Nelson SJ.
    Arch Neurol; 2004 Jul 15; 61(7):1081-6. PubMed ID: 15262739
    [Abstract] [Full Text] [Related]

  • 12. Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
    Khan O, Shen Y, Bao F, Caon C, Tselis A, Latif Z, Zak I.
    J Neuroimaging; 2008 Jul 15; 18(3):314-9. PubMed ID: 18304034
    [Abstract] [Full Text] [Related]

  • 13. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Biernacki K, Antel JP, Blain M, Narayanan S, Arnold DL, Prat A.
    Arch Neurol; 2005 Apr 15; 62(4):563-8. PubMed ID: 15824253
    [Abstract] [Full Text] [Related]

  • 14. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug 15; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 15. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW.
    Ann Neurol; 1994 Aug 15; 36(2):157-65. PubMed ID: 8053651
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
    Mostert JP, Sijens PE, Oudkerk M, De Keyser J.
    Neurosci Lett; 2006 Jul 10; 402(1-2):22-4. PubMed ID: 16644118
    [Abstract] [Full Text] [Related]

  • 17. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 18. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug 14; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 19. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.
    Narayanan S, Fu L, Pioro E, De Stefano N, Collins DL, Francis GS, Antel JP, Matthews PM, Arnold DL.
    Ann Neurol; 1997 Mar 14; 41(3):385-91. PubMed ID: 9066360
    [Abstract] [Full Text] [Related]

  • 20. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S, Li LM, Costallat LT, Cendes F.
    Brain; 2005 Dec 14; 128(Pt 12):2933-40. PubMed ID: 16195241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.